Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Regulation of HIV production by blood mononuclear cells from HIV-infected donors: I. Lack of correlation between HIV-1 production and T cell activation.

Moran PA, Diegel ML, Sias JC, Ledbetter JA, Zarling JM.

AIDS Res Hum Retroviruses. 1993 May;9(5):455-64.

PMID:
8318272
2.

Regulation of HIV production by blood mononuclear cells from HIV-infected donors: II. HIV-1 production depends on T cell-monocyte interaction.

Diegel ML, Moran PA, Gilliland LK, Damle NK, Hayden MS, Zarling JM, Ledbetter JA.

AIDS Res Hum Retroviruses. 1993 May;9(5):465-73.

PMID:
8100439
3.

Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.

Hu SL, Travis BM, Stallard V, Abrams K, Misher L, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, et al.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1489-94. No abstract available.

PMID:
1466988
4.
5.

Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.

Hu SL, Abrams K, Misher L, Stallard V, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE.

J Med Primatol. 1992 Feb-May;21(2-3):119-25.

PMID:
1433262
6.

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

Hu SL, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE.

Science. 1992 Jan 24;255(5043):456-9.

PMID:
1531159
7.

HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles.

Haffar OK, Smithgall MD, Moran PA, Travis BM, Zarling JM, Hu SL.

Virology. 1991 Aug;183(2):487-95.

PMID:
1906660
8.

Inhibition of HIV-1 replication in seropositive patients' CD4+ T-cells by pokeweed antiviral protein-monoclonal antibody conjugates.

Zarling JM, Moran PA, Haffar O, Diegel M, Myers DE, Kuelbeck V, Ledbetter JA, Uckun FM.

Int J Immunopharmacol. 1991;13 Suppl 1:63-8.

PMID:
1688086
9.

Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.

Hu SL, Travis BM, Garrigues J, Zarling JM, Sridhar P, Dykers T, Eichberg JW, Alpers C.

Virology. 1990 Nov;179(1):321-9.

PMID:
2219727
10.

HIV update.

Zarling JM, Moran PA.

Nursing (Lond). 1990 Oct 25-Nov 7;4(21):7. No abstract available.

PMID:
2250826
11.

Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.

Zarling JM, Moran PA, Haffar O, Sias J, Richman DD, Spina CA, Myers DE, Kuebelbeck V, Ledbetter JA, Uckun FM.

Nature. 1990 Sep 6;347(6288):92-5.

PMID:
1975641
12.

HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells.

Zarling JM, Ledbetter JA, Sias J, Fultz P, Eichberg J, Gjerset G, Moran PA.

J Immunol. 1990 Apr 15;144(8):2992-8.

PMID:
1969880
13.

Hepatitis B surface antigen-specific CD8-positive T cell clones. Antigen specificity and interleukin-2 production.

Zhang DF, Zarling JM, Wener MH.

Chin Med J (Engl). 1990 Mar;103(3):216-22.

PMID:
1695132
14.

Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.

Hu SL, Zarling JM, Chinn J, Travis BM, Moran PA, Sias J, Kuller L, Morton WR, Heidecker G, Benveniste RE.

Proc Natl Acad Sci U S A. 1989 Sep;86(18):7213-7.

15.

Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M.

Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei CM, et al.

Mol Cell Biol. 1989 Jul;9(7):2847-53.

16.

Identification and characterization of cellular receptors for the growth regulator, oncostatin M.

Linsley PS, Bolton-Hanson M, Horn D, Malik N, Kallestad JC, Ochs V, Zarling JM, Shoyab M.

J Biol Chem. 1989 Mar 15;264(8):4282-9.

18.

Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates.

Zarling JM, Moran PA, Grosmaire LS, McClure J, Shriver K, Ledbetter JA.

J Immunol. 1988 Apr 15;140(8):2609-13.

PMID:
2965725
19.

Primate models for evaluation of AIDS vaccines.

Zarling JM.

AIDS. 1988;2 Suppl 1:S113-7. Review. No abstract available.

PMID:
3147661
20.

T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees.

Eichberg JW, Zarling JM, Alter HJ, Levy JA, Berman PW, Gregory T, Lasky LA, McClure J, Cobb KE, Moran PA, et al.

J Virol. 1987 Dec;61(12):3804-8.

21.
22.

Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ.

Proc Natl Acad Sci U S A. 1986 Dec;83(24):9739-43.

23.

T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.

Zarling JM, Morton W, Moran PA, McClure J, Kosowski SG, Hu SL.

Nature. 1986 Sep 25-Oct 1;323(6086):344-6.

PMID:
3093891
24.
25.

Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.

Zarling JM, Moran PA, Burke RL, Pachl C, Berman PW, Lasky LA.

J Immunol. 1986 Jun 15;136(12):4669-73.

PMID:
2423598
30.

Autologous herpes simplex virus-infected cells are lysed by human natural killer cells.

Yasukawa M, Zarling JM.

J Immunol. 1983 Oct;131(4):2011-6. No abstract available.

PMID:
6311903
33.

Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes.

Zarling JM, Kay NE, Grant B, Yasukawa M, Bach FH.

Cancer Immunol Immunother. 1983;15(3):237-9.

PMID:
6604571
34.

Phenotypes of human natural killer cell populations detected with monoclonal antibodies.

Zarling JM, Clouse KA, Biddison WE, Kung PC.

J Immunol. 1981 Dec;127(6):2575-80.

PMID:
7299137
35.
37.

Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.

Ziegler HW, Kay NE, Zarling JM.

Int J Cancer. 1981 Mar 15;27(3):321-7.

PMID:
6169660
39.
40.
41.

Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues.

Zarling JM, Schlais J, Eskra L, Greene JJ, Ts'o PO, Carter WA.

J Immunol. 1980 Apr;124(4):1852-7. No abstract available.

PMID:
6154082
42.
43.

Antitumor cytotoxic T cells and non-T-cells generated by allosensitization in vitro.

Bach FH, Paciucci PA, Macphail S, Sondel PM, Alter BJ, Zarling JM.

Transplant Proc. 1980 Mar;12(1):2-7. No abstract available.

PMID:
6445107
44.

Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.

Paciucci PA, Macphail S, Zarling JM, Bach FH.

J Immunol. 1980 Jan;124(1):370-5. No abstract available.

PMID:
6765969
45.

Continuous culture of T cells cytotoxic for autologous human leukaemia cells.

Zarling JM, Bach FH.

Nature. 1979 Aug 23;280(5724):685-8. No abstract available.

PMID:
224318
46.

Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.

Zarling JM, Eskra L, Borden EC, Horoszewicz J, Carter WA.

J Immunol. 1979 Jul;123(1):63-70. No abstract available.

PMID:
286738
47.

Elicitation of anti-leukemia cytotoxic responses.

Bach FH, Sondel PM, Zarling JM.

Haematol Blood Transfus. 1979;23:369-76.

PMID:
161756
48.

Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

Zarling JM, Sosman J, Eskra L, Borden EC, Horoszewicz JS, Carter WA.

J Immunol. 1978 Nov;121(5):2002-4.

PMID:
309487
49.

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Zarling JM, Robins HI, Raich PC, Bach FH, Bach ML.

Nature. 1978 Jul 20;274(5668):269-71. No abstract available.

PMID:
308186

Supplemental Content

Loading ...
Support Center